<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "epoprostenol (CARIPUL) inj VIAL">
<dose><value>2</value>
<value>3</value>
<value>4</value>
<value>5</value>
<value>6</value>
<value>7</value>
<value>8</value>
<value>9</value>
<value>10</value>
<value>11</value>
<value>12</value>
<value>13</value>
<value>14</value>
<value>15</value>
<value>16</value>
<value>17</value>
<value>18</value>
<value>19</value>
<value>20</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>epoprostenol (CARIPUL) inj VIAL</value>
</drugname><strength><value>0.5 mg</value>
<value>1.5 mg</value>
</strength><frequency><value>CONTINUOUS</value>
</frequency><instruction><value>Administer as continuous infusion.  Adjust infusion by 1 to 2 ng/kg/minute every 15 minutes to allow assessment of clinical response/tolerability/adverse effects. (1 mcg = 1000 ng)</value>
</instruction><volume></volume><units><value>ng/kg/minute</value>
</units><additionalnotes></additionalnotes><population></population><indicationprn></indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=6861</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=6862</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Vasodilating Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose></maximumprndose><din><value>02397447</value>
<value>02397455</value>
</din><type><value>Medication/IV Therapy</value>
</type></drug>